Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal
Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal
Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal
Submitted by
admin
on April 10, 2012 - 9:31am
Source:
Yahoo/AP
News Tags:
JNJ
Risperdal
Arkansas
Janssen
Headline:
Closing arguments set in Arkansas trial over J&J subsidiary's antipsychotic drug Risperdal
Do Not Allow Advertisers to Use My Personal information
